nasdaq:fixx
|
15079527
|
Apr 10th, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
70.00
|
Open
|
|
Apr 9th, 2024 11:01PM
|
Apr 9th, 2024 11:01PM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 9th, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
70.00
|
Open
|
|
Apr 8th, 2024 11:12PM
|
Apr 9th, 2024 09:58AM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 8th, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
70.00
|
Open
|
|
Apr 7th, 2024 11:37PM
|
Apr 8th, 2024 06:55PM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 7th, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
71.00
|
Open
|
|
Apr 6th, 2024 11:08PM
|
Apr 6th, 2024 11:08PM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 6th, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
71.00
|
Open
|
|
Apr 5th, 2024 11:08PM
|
Apr 5th, 2024 11:08PM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 5th, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
71.00
|
Open
|
|
Apr 4th, 2024 11:35PM
|
Apr 4th, 2024 11:35PM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 4th, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
71.00
|
Open
|
|
Apr 3rd, 2024 11:19PM
|
Apr 4th, 2024 09:31AM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 3rd, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
71.00
|
Open
|
|
Apr 2nd, 2024 11:05PM
|
Apr 3rd, 2024 09:56AM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 2nd, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
71.00
|
Open
|
|
Apr 1st, 2024 11:35PM
|
Apr 2nd, 2024 08:23AM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|
nasdaq:fixx
|
15079527
|
Apr 1st, 2024 12:00AM
|
Homology Medicines, Inc.
|
9.4K
|
71.00
|
Open
|
|
Apr 1st, 2024 04:07PM
|
Apr 1st, 2024 04:07PM
|
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.
|
Open
|
Gene Editing, Gene Therapy, Biotechnology, and Rare Diseases
|
Open
|
1 Patriots Park
|
Bedford
|
Massachusetts
|
US
|
01730
|
|
Homology Medicines
|
|
|